BCR and TLR Signaling Pathways Are Recurrently Targeted by Genetic Changes in Splenic Marginal Zone Lymphomas

Haematologica- Italy

doi 10.3324/haematol.2011.054080

Full Text

Abstract

Available in

Categories

Date

November 18, 2011

Authors

S. Kocialkowski

Publisher

Ferrata Storti Foundation (Haematologica)

Related search

Splenic Marginal Zone Lymphomas Appear to Originate From Different B Cell Types

American Journal of Pathology

Forensic Medicine

English

Splenic Marginal Zone Lymphoma

English

CD79B and MYD88 Mutations in Splenic Marginal Zone Lymphoma

English

The Multiple Faces of Marginal Zone Lymphomas

Hematological Oncology

Cancer Research

English

A Case of Splenic Marginal Zone Lymphoma

Japanese Journal of Gastroenterological Surgery

Gastroenterology

English

Recurrent Autoimmune Hemolytic Anemia in Splenic Marginal Zone Lymphoma

Journal of Community Hospital Internal Medicine Perspectives

Internal Medicine

English

Primary Splenic Marginal Zone Lymphoma: A Case Report

Forensic Medicine

English

Idelalisib and Rituximab in 17p Deletion–Positive Splenic Marginal Zone Lymphoma

Journal of the National Comprehensive Cancer Network : JNCCN

English

Regulation of TLR Signaling Pathways by microRNAs: Implications in Inflammatory Diseases

Central-European Journal of Immunology

English